What is TuHURA Biosciences, Inc.'s stock-based comp?

TuHURA Biosciences, Inc. (HURA) reported stock-based comp of $2.8M in Q1 2026.

How has TuHURA Biosciences, Inc.'s stock-based comp changed year-over-year?

TuHURA Biosciences, Inc.'s stock-based comp increased by 96.3% year-over-year, from $1.42M to $2.8M.

What is the long-term trend for TuHURA Biosciences, Inc.'s stock-based comp?

Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s stock-based comp has grown at a 266.3% compound annual growth rate (CAGR), from $478.89K to $6.42M.

TuHURA Biosciences, Inc. HURA Stock-Based Comp

Stock-Based Comp at other companies

CTO

Citius Oncology, Inc.CTOR

——

Other financials

Income statement

See full

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Balance sheet

See full

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Cash flow

See full

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Valuation

See full

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Returns & leverage

See full

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s stock-based comp?: TuHURA Biosciences, Inc. (HURA) reported stock-based comp of $2.8M in Q1 2026.
How has TuHURA Biosciences, Inc.'s stock-based comp changed year-over-year?: TuHURA Biosciences, Inc.'s stock-based comp increased by 96.3% year-over-year, from $1.42M to $2.8M.
What is the long-term trend for TuHURA Biosciences, Inc.'s stock-based comp?: Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s stock-based comp has grown at a 266.3% compound annual growth rate (CAGR), from $478.89K to $6.42M.